Lv22
170 积分 2025-10-11 加入
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
1个月前
已完结
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
1个月前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
1个月前
已完结
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
1个月前
已完结
The RNA m6A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
3个月前
已完结
Disease Burden and Treatment Pattern in Chinese Moderate-to-Severe Asthma Patients: Baseline Analysis of a Real-world, Multicentre Study (PRESENT)
4个月前
已完结
The Asthma–COPD Overlap Syndrome
5个月前
已完结
Transforming COPD management: the role of dupilumab
6个月前
已完结
FeNO or no FeNO in COPD?
6个月前
已完结
皖公网安备34019202002308
